U.S.Depyrogenated Sterile Empty Vials Market Size, Share & Trends Analysis
Report By Product (2 ml, 5 ml, 10 ml, 20 ml), By End Use (Clinical Labs,
Componding Pharmacies), And Segment Forecasts, 2018 - 2025
The U.S. depyrogenated sterile empty vials market size is likely to reach USD 3.5 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.2% during the forecast period. Technological advancements in pharmaceutical packaging process, growing funding by government organizations, and flourishing biologics market in the U.S. are some of the key trends escalating market growth. Stringent regulations laid by the government for parenteral are also poised to augment the market.
Rising number of clinical labs in the country
is resulting in an increased number of medical and diagnostic tests. This, in
turn, is fueling the demand for depyrogenated sterile empty vials. Increasing
number of compounding laboratories and research institutes in the U.S. is
boosting the demand for these vials in the market. Moreover, continual growth
in the pharmaceutical and biotechnology industry is further projected to drive
the market.
Increasing number of collaborations in
order to achieve innovative packaging technology is also providing an upthrust
to the market. Rising incidence of infectious & non-infectious diseases and
growing number of clinical studies are translating into a greater demand for
these vials. Besides this, the government is backing the promotion of
pharmaceutical, medical, and biotechnological researches, which is anticipated
to work in favor of the market.
Access Research Report of U.S.
Depyrogenated Sterile Empty Vials Market @ www.grandviewresearch.com/industry-analysis/us-depyrogenated-sterile-empty-vials-market
Further key findings from the report suggest:
· More than 20 ml depyrogenated sterile empty
vials emerged as the largest segment in terms of revenue in 2017 owing to
rising incidence of infectious & non-infectious diseases and increasing
investments in the biopharmaceutical sector
· Others, which include pharmaceutical
manufacturers and academic & research institutes, formed the most prominent
end-use segment in 2017. The growth of the segment can be attributed to
expanding base of medical & biotech research institutes and upswing in
pharmaceutical manufacturing
· Thermo Fisher Scientific, Inc.; Gerresheimer
AG; SCHOTT AG; and DWK Life Sciences are the major players operating in the
market. This market is considerably fragmented and market entry barrier is
high.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the U.S.
depyrogenated sterile empty vials market on the basis of product and end-use:
Depyrogenated Sterile Empty Vials Product
Outlook (Revenue, USD Million, 2014 - 2025)
·
2 ml
·
5 ml
·
10 ml
·
20 ml
·
More than 20 ml
Depyrogenated Sterile Empty Vials End-use
Outlook (Revenue, USD Million, 2014 - 2025)
·
Clinical Labs
·
Compounding Labs
·
Others
Access Press Release of
U.S. Depyrogenated Sterile Empty Vials Market@ www.grandviewresearch.com/press-release/us-depyrogenated-sterile-empty-vials-market-analysis
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment